Are Cathepsin K Inhibitors Just Another Class of Anti-Resorptives?CHAMBERS, T. J; TOBIAS, J. H.The Journal of clinical endocrinology and metabolism. 2013, Vol 98, Num 11, pp 4329-4331, issn 0021-972X, 3 p.Article

Waldeström macroglobulinaemia relapsing with focal bone disease and achieving major response with single-agent zoledronic acidBAKHOUS, Aziz; HONGYUN ZHU; WAHEED, Sarah et al.British journal of haematology. 2013, Vol 163, Num 3, issn 0007-1048, p. 293Article

The Effect of Long-term Alendronate Treatment on Cortical Thickness of the Proximal FemurUNNANUNTANA, Aasis; ASHFAQ, Kashif; TON, Quang V et al.Clinical orthopaedics and related research. 2012, Vol 470, Num 1, pp 291-298, issn 0009-921X, 8 p.Article

Local application of zoledronate for maximum anchorage during space closureAJ ORTEGA, Adam J; CAMPBELL, Phillip M; HINTON, Robert et al.American journal of orthodontics and dentofacial orthopedics. 2012, Vol 142, Num 6, pp 780-791, issn 0889-5406, 12 p.Article

Liposomal alendronate for the treatment of restenosisGUTMAN, Dikla; GOLOMB, Gershon.Journal of controlled release. 2012, Vol 161, Num 2, pp 619-627, issn 0168-3659, 9 p.Article

En bref - Risédronate à libération retardée = In brief: delayed-release risedronate (Atelvia)The Medical letter on drugs and therapeutics (Edition française). 2011, Vol 33, Num 8, issn 0253-8512, p. 29Article

Effect of Zoledronate on Oral Wound Healing in RatsYAMASHITA, Junro; KOI, Kiyono; YANG, Dong-Ye et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1405-1414, issn 1078-0432, 10 p.Article

Effects of Intravenous Zoledronic Acid Plus Subcutaneous Teriparatide [rhPTH(1―34)] in Postmenopausal OsteoporosisCOSMAN, Felicia; FINK ERIKSEN, Erik; BUCCI-RECHTWEG, Christina et al.Journal of bone and mineral research (Print). 2011, Vol 26, Num 3, pp 503-511, issn 0884-0431, 9 p.Article

Nanotechnologies to use zoledronic acid as a potent antitumoral agentSALZANO, G; MARRA, M; LEONETTI, C et al.Journal of drug delivery science and technology. 2011, Vol 21, Num 3, pp 283-284, issn 1773-2247, 2 p.Article

Jaw bone changes in rats after treatment with zoledronate and pamidronateSENEL, Figen Cizmeci; DUMAN, Mine Kadioglu; MUCI, Efnan et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2010, Vol 109, Num 3, pp 385-391, issn 1079-2104, 7 p.Article

Necrotic Actions of Nitrogen-Containing Bisphosphonates and Their Inhibition by Clodronate, a Non-Nitrogen-Containing Bisphosphonate in Mice : Potential for Utilization of Clodronate as a Combination Drug with a Nitrogen-Containing BisphosphonateOIZUMI, Takefumi; YAMAGUCHI, Kouji; FUNAYAMA, Hiromi et al.Basic & clinical pharmacology & toxicology (Print). 2009, Vol 104, Num 5, pp 384-392, issn 1742-7835, 9 p.Article

High-Dose Zoledronic Acid Impacts Bone Remodeling with Effects on Osteoblastic Lineage and Bone Mechanical PropertiesPOZZI, Samantha; VALLET, Sonia; SCHOONMAKER, Jesse et al.Clinical cancer research (Print). 2009, Vol 15, Num 18, pp 5829-5839, issn 1078-0432, 11 p.Article

Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy : implications from clinical studies with ibandronatePAPAPOULOS, S. E; SCHIMMER, R. C.Postgraduate medical journal. 2008, Vol 84, Num 992, pp 307-312, issn 0032-5473, 6 p.Article

Liposomes for targeting of antigens and drugs : Immunoadjuvant activity and liposome-mediated depletion of macrophagesVAN ROOIJEN, Nico.Journal of drug targeting. 2008, Vol 16, Num 7-8, pp 529-534, issn 1061-186X, 6 p.Article

Zebra Lines of Pamidronate Therapy in ChildrenAL MUDERIS, M; AZZOPARDI, T; CUNDY, P et al.Journal of bone and joint surgery. American volume. 2007, Vol 89A, Num 7, pp 1511-1516, issn 0021-9355, 6 p.Article

Antiresorptive Drugs Beyond Bisphosphonates and Selective Oestrogen Receptor Modulators for the Management of Postmenopausal OsteoporosisREGINSTER, J. Y; NEUPREZ, A; BEAUDART, C et al.Drugs & aging. 2014, Vol 31, Num 6, pp 413-424, issn 1170-229X, 12 p.Article

A Model of BMD Changes After Alendronate Discontinuation to Guide Postalendronate BMD MonitoringMCNABB, Brian; VITTINGHOFF, Eric; EASTELL, Richard et al.The Journal of clinical endocrinology and metabolism. 2014, Vol 99, Num 11, pp 4094-4100, issn 0021-972X, 7 p.Article

Circulating γδ T Cells and the Risk of Acute-Phase Response After Zoledronic Acid AdministrationROSSINI, Maurizio; ADAMI, Silvano; VIAPIANA, Ombretta et al.Journal of bone and mineral research (Print). 2012, Vol 27, Num 1, pp 227-230, issn 0884-0431, 4 p.Article

The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone massANASTASILAKIS, Athanasios D; POLYZOS, Stergios A; DELAROUDIS, Sideris et al.Clinical endocrinology (Oxford. Print). 2012, Vol 77, Num 6, pp 816-822, issn 0300-0664, 7 p.Article

Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targetingNASR, Maha; AWAD, Gehanne A. S; MANSOUR, Samar et al.European journal of pharmaceutics and biopharmaceutics. 2011, Vol 79, Num 3, pp 601-611, issn 0939-6411, 11 p.Article

Dose-dependent differential effects of risedronate on gene expression in osteoblastsWANG, J; STERN, P. H.Biochemical pharmacology. 2011, Vol 81, Num 8, pp 1036-1042, issn 0006-2952, 7 p.Article

Proton Pump Inhibitor Use and the Antifracture Efficacy of AlendronateABRAHAMSEN, Bo; EIKEN, Pia; EASTELL, Richard et al.Archives of internal medicine (1960). 2011, Vol 171, Num 11, pp 998-1004, issn 0003-9926, 7 p.Article

Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case seriesSIVENDRAN, Shanthi; HARVEY, Harold; LIPTON, Allan et al.International journal of hematology. 2011, Vol 93, Num 6, pp 782-786, issn 0925-5710, 5 p.Article

The Effect of Weekly Risedronate on Periprosthetic Bone Resorption Following Total Hip Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled TrialOG, Sköldenberg; MO, Salemyr; HS, Boden et al.Orthopedics (Thorofare). 2011, Vol 34, Num 12, issn 0147-7447, p. 989Article

Efficacy of Continued Alendronate for Fractures in Women With and Without Prevalent Vertebral Fracture: The FLEX TrialSCHWARTZ, Ann V; BAUER, Douglas C; BLACK, Dennis M et al.Journal of bone and mineral research (Print). 2010, Vol 25, Num 5, pp 976-982, issn 0884-0431, 7 p.Article